4//SEC Filing
Halladay Benjamin 4
Accession 0001953943-25-000004
CIK 0001434868other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:06 PM ET
Size
18.1 KB
Accession
0001953943-25-000004
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-09-17$2.81/sh−7,046$19,785→ 474,862 total
Footnotes (2)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.
- [F2]Includes 7,446 shares recently acquired in Esperion's Employee Stock Purchase Plan.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001953943
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:06 PM ET
- Size
- 18.1 KB